Education
About Us
Working with TipRanks
Follow Us
HilleVax, Inc (HLVX)
:HLVX
HLVX Stock Chart & Stats
$2.09
$0.00(0.00%)
―
--
Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
HilleVax, Inc News
HLVX FAQ
What was HilleVax, Inc’s price range in the past 12 months?
Currently, no data Available
What is HilleVax, Inc’s market cap?
Currently, no data Available
When is HilleVax, Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were HilleVax, Inc’s earnings last quarter?
Currently, no data Available
Is HilleVax, Inc overvalued?
According to Wall Street analysts HilleVax, Inc’s price is currently Undervalued.
Does HilleVax, Inc pay dividends?
HilleVax, Inc does not currently pay dividends.
What is HilleVax, Inc’s EPS estimate?
HilleVax, Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does HilleVax, Inc have?
Currently, no data Available
What happened to HilleVax, Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of HilleVax, Inc?
Currently, no hedge funds are holding shares in HLVX
Company Description
HilleVax, Inc
HilleVax, Inc. (HLVX) is a biopharmaceutical company focused on developing novel vaccines. The company's primary area of expertise is in the prevention of infectious diseases through innovative vaccine solutions. HilleVax leverages cutting-edge research and development to bring new vaccines from concept to market, aiming to address significant unmet medical needs across various populations.
Ownership Overview
―
Insiders
2.44%
Mutual Funds
― Other Institutional Investors
97.56% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---